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An emerging subtype of methicillin-resistant Staphy-
lococcus aureus (MRSA), clonal complex (CC) 398, is as-
sociated with animals, particularly pigs. We conducted a 
matched case–control and a case–case study comparing 
21 CC398 case-patients with 2 controls randomly selected 
from the Danish Civil Registry and 2 case-patients infected 
with MRSA other than CC398. On farms of case-patients, 
animals were examined for MRSA. Thirteen case-patients 
reported pig exposure. Living or working on farms with ani-
mals was an independent risk factor for CC398 in the case–
control (matched odds ratio [MOR] 35.4, 95% conﬁ  dence in-
terval [CI] 2.7–469.8) and the case–case study (MOR 14.5, 
95%CI 2.7–76.7). History of hospitalization was associated 
with an increased risk only in the case–control study (MOR 
11.4, 95% CI 1.4–94.8). A total of 23 of 50 pigs on 4 of 5 
farms were positive for CC398. Our results, corroborated by 
microbiologic testing, demonstrate that pigs are a source of 
CC398 in Denmark.
M
ethicillin-resistant Stapylococcus aureus (MRSA) is 
becoming increasingly recognized among persons 
in the community without established risk factors (1,2). 
MRSA primarily causes human disease and animals have 
not, until now, been considered a source of infection.
It has recently become apparent that animals, particu-
larly pigs, can constitute a separate MRSA reservoir and 
be a source of a novel and rapidly emerging type of MRSA 
in humans; namely MRSA clonal complex (CC)398 by 
multilocus sequence typing (MLST) (3). MRSA CC398 
consists of 8 MLST types (www.saureus.mlst.net), the pre-
dominant type being sequence type (ST)398, and a range of 
closely related protein A (spa) gene types (i.e., t011, t034, 
t108, and t1793) (4,5) .
Although transmission appears to be primarily between 
animals, indistinguishable isolates have been found in their 
human contacts, particularly those with occupational ex-
posure (3–7). MRSA CC398 (ST398) was ﬁ  rst detected in 
4 pigs and 1 healthy pig farmer in France (3,8). Clinical 
infection was described in the daughter of a pig farmer in 
the Netherlands in 2004 (7). That study showed that 23% 
of pig farmers in a small survey in the same region were 
seropositive for MRSA CC398.
Denmark has a low incidence of MRSA. In 2006, only 
706 new MRSA patients (colonization only or infection) 
were reported, which corresponds to 13/100,000 popula-
tion (9). To maintain this status, Denmark has adopted a 
strict “Search and Destroy” policy, which includes active 
screening of at-risk persons at admission to a hospital (10). 
Prompted by reports from the Netherlands, we identiﬁ  ed a 
small (<1% of all MRSA patients) but increasing number 
of MRSA CC398 human patients after 2003. Furthermore, 
CC398 was detected in a pig in Denmark in 2006 (11). 
With an annual production of ≈25 million slaughter pigs 
(www.dst.dk), Denmark has a large potential reservoir for 
MRSA CC398.
We report results of an analytical study of MRSA 
CC398, in parallel with systematic farm and microbiologic 
investigations, to identify risk factors for MRSA CC398 ac-
Pigs as Source of Methicillin-
Resistant Staphylococcus aureus 
CC398 Infections in Humans, 
Denmark 
Hannah C. Lewis, Kåre Mølbak, Catrin Reese, Frank M. Aarestrup, Mette Selchau, 
Marit Sørum, and Robert L. Skov
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 9, September 2008  1383 
Author afﬁ  liations: Statens Serum Institut, Copenhagen, Denmark 
(H.C. Lewis, K. Mølbak, M. Selchau, M. Sørum, R.L. Skov); Eu-
ropean Programme for Intervantion Epidemiology Training (H.C. 
Lewis); Vejle Hospital, Vejle, Denmark (C. Reese); and Technical 
University of Denmark, Copenhagen (F.M. Aarestrup)
DOI: 10.320 07-1576 ResearchRESEARCH
quisition in persons in Denmark. Although farm and pig ex-
posure have been postulated as risk factors after interviews 
with MRSA CC398 patients in other studies (4,6,7,12), no 
previous study has included interviews with control popu-
lations to determine if these exposures were higher than 
would be expected in the general population.
Methods
Surveillance
In Denmark, MRSA isolates from all human patients 
have been referred to Statens Serum Institut since 1988 for 
characterization and national surveillance. Epidemiologic 
and clinical information has been obtained prospectively 
since 1999 on all patients.
Case-Patients and Controls
We conducted a matched case–control study com-
paring human case-patients with MRSA CC398 during 
2004–2007 with 2 population controls. In parallel, we 
conducted a case–case study comparing the same MRSA 
CC398 case-patients to 2 case-patients of community-
detected MRSA of a type other than CC398 (non-CC398 
case-patients). Eligible case-patients were persons with a 
conﬁ  rmed diagnosis of MRSA with spa types related to 
CC398 (carriage or infection) during the study period: Oc-
tober 29, 2003 (ﬁ  rst human diagnosed) to May 31, 2007. 
Where household clusters were identiﬁ  ed, secondary case-
patients were excluded from the study. Population controls 
were selected randomly from the Danish Civil Registry 
System and matched by sex, date of birth, and residence 
in the same municipality. Non-CC398 case-patients were 
selected from the national MRSA database and matched 
by sex, residence in the same region (Zealand, Jutland, or 
Funen), age group (± 10 years for adults and ± 3 years for 
persons <18 years of age) according to whether infected or 
a carrier, and similar time of diagnosis (90% ± 4 months) to 
limit differential recall bias. When >2 non-CC398 MRSA 
case-patients were identiﬁ  ed within ± 4 months of diagno-
sis of the case-patient, 2 were randomly selected from the 
list generated.
Data Collection
After written informed consent was obtained, case-
patients, controls, and non-CC398 case-patients were in-
terviewed by using a structured telephone-administered 
questionnaire. Questions captured demographic and clini-
cal data as well as information on known/identiﬁ  ed risk 
factors for MRSA (including hospitalization and other 
medical exposures, contact sports, and travel) and hy-
pothesized farm and animal exposures for MRSA CC398 
(including living or working on a farm, exposure to farm 
animals, contact with farm workers, preference for eating, 
and contact with pets) in the year before case-patient diag-
nosis. Data were double-entered into Epidata version 3.1 
(Statens Serum Institut, Copenhagen, Denmark) and col-
lected and handled according to the requirements of the 
Danish Data Protection Agency. The study did not require 
ethical approval.
Statistical Analysis
Univariable and multivariable conditional logistic re-
gression analyses were conducted to estimate matched odds 
ratios (MORs). Unmatched logistic regression was used for 
variables for which MORs could not be calculated because 
not enough controls were exposed to MRSA. Multivariable 
conditional logistic regression analysis included signiﬁ  cant 
variables (based on a p value of 0.05) from univariable 
analysis. Stepwise exclusion was used, and variables were 
tested for signiﬁ  cance by using the likelihood ratio test. 
Stata version 9.2 software (StataCorp, College Station, TX, 
USA) was used for all analyses.
Farm Investigations
For case-patients, controls, and non-CC398 case-
patients reporting contact with production animals, the farm 
owner was contacted. If the owner consented, nasal swabs 
were taken from 10 randomly selected animals (from 10 
different pens where possible) and tested for MRSA.
Microbiologic Analysis
Human isolates were tested by using PCR to iden-
tify the mecA gene (13), pulsed-ﬁ  eld gel electrophoresis 
(PFGE) with the Harmony protocol (14), spa typing (15), 
and staphylococcal cassette chromosome mec (SCCmec) 
typing (16). Isolates were also tested for lukF/lukS genes 
encoding Panton-Valentine leukocidin (PVL) (17). Results 
of PFGE and spa typing were interpreted by using BioNu-
merics version 4.6 software (Applied Maths, Sint-Martens-
Latem, Belgium). Because spa typing is acknowledged as 
being a proxy for MLST, the MLST clonal complex an-
notation was inferred on the basis of spa types. One of 
the human isolates was typed by MLST for conﬁ  rmation. 
Furthermore, a random selection of 7 isolates were tested 
by PCR for the exotoxin genes tst, eta, and etb encoding 
staphylococcal toxic shock syndrome toxin 1, exfoliative 
toxin A, and exfoliative toxin B, respectively (18).
Animal swabs were plated directly on CHROM-
MRSA agar (Becton Dickinson, Heidelberg, Germany) 
and blood agar (containing 5% bovine blood) and subse-
quently placed in selective broth (tryptic soy broth, 2.5% 
salt, aztreonam [20 mg/L], and cefoxitin [3.5 mg/L]; SSI 
Diagnostika, Hillerød, Denmark). After incubation for 24 
hours, the CHROM-MRSA agar was inspected for putative 
MRSA. Subcultivation on CHROM-MRSA was conducted 
with samples from the enrichment broth. Possible MRSA 
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colonies were subcultivated on blood agar plates, identiﬁ  ed 
by PCR for the mecA gene (13), and subjected to spa typing 
and SCCmec typing.
Human and animal isolates underwent antimicrobial 
drug susceptibility testing by using disc diffusion (D) with 
Neosensitabs (Rosco, Taastrup, Denmark) on Danish blood 
agar (SSI Diagnostika) or microbroth dilution (M) (19). 
Susceptibility tests were performed for tetracycline (D and 
M), erythromycin (D and M), streptomycin (D and M), ka-
namycin (D), norﬂ  oxacin (D), pencillin (D), clindamycin 
(D), fusidic acid (D), rifampicin (D), cefoxitin (D), ceftio-
fur (M), chloramphenicol (M), ciproﬂ  oxacin (M), ﬂ  orfeni-
col (M), spectinomycin (M), sulfamethoxazole (M), tiamu-
lin (M), and trimethoprim (M).
Results
Descriptive Epidemiology
Thirty-one case-patients with MRSA with spa types 
related to MRSA CC398 were detected from October 29, 
2003, through February 16, 2007. Of these, 6 were ex-
cluded from the study because they were secondary case-
patients (3 family clusters). Of the remaining eligible case-
patients, we were unable to interview 4 because of a death 
(n = 1) and refusal to participate (n = 3). The questionnaire 
was therefore administered to 21 of 25 primary case-pa-
tients. Median age of the case-patients was 29 years (age 
range 8 months to 80 years), and 13 (62%) were female. 
Three case-patients reported having Dutch relatives, and 2 
case-patients had a connection to the People’s Republic of 
China; 1 case-patient was an adopted child from China and 
another case-patient had adopted a child from China.
Ten case-patients (48%) reported having had an in-
fection, of which all were skin and soft tissue infections. 
Moreover, sinusitis developed in 1 case-patient, and a se-
vere invasive infection with multiorgan failure after knee 
surgery developed in another case-patient.
Univariable Analysis
Several exposure variables related to farms and animals 
were associated with CC398 in the case–control and case–
case studies (Table 1). Case–control analysis also identi-
ﬁ  ed 4 medical-related risk factors (Table 1). No association 
was found in the case–control and case–case studies for 
the following exposures: travel 12 months before diagno-
sis, working in the healthcare sector, contact with primary 
healthcare sector (doctor, specialist), visiting an emergency 
department, presence of a person in the household with a 
skin condition, presence of a person in the household with 
staphylococcal infection, smoking daily, contact sports, 
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Table 1. Statistically significant associations by univariable analysis for infection with MRSA CC398, Denmark* 




n = 21 
Case–control study, 
population controls, n = 42 
Case–case study, non-CC398 
case-patients, n = 39 
Animal and farm-related exposures 
  Lived or worked on farm with animals  14 (67)  22.1 (2.9–170.3)  11.6 (2.6–51.7) 
  Worked with animals or meat  11 (50)  16.2 (2.0–127.8)  f†
  Worked on farm with animals  10 (48)  f† f†
  Lived on farm with animals  9 (43)  6.9 (1.5–32.8)  7.9 (1.7–36.7) 
  Exposure to pigs  13 (62)  f† f†
  Exposure to cattle  6 (29)  f† f†
  Exposure to other farm animals (hens, goats,  
 sh  eep) 
7 (33)  11.1 (1.4–92.4)  5.9 (1.2–28.8) 
  Provided antimicrobial drugs to animals  10 (48)  f† f†
  Contact with farm workers  16 (76)  5.2 (1.4–19.3)  f†
  Contact with farmer  14 (67)  3.2 (1.0–10.6)  f†
  Contact with veterinarian  7 (33)  6.3 (1.3–30.7)  6.6 (1.4–31.8) 
  Lived in countryside  13 (62)  7.2 (1.5–33.8)  5.2 (1.4–18.9) 
  Had cat in home  11 (50)  3.2 (1.0–10.6)  3.4 (1.1–9.9) 
  Used manure in garden  7 (33)  3.2 (0.9–11.0)  6.6 (1.4–31.8) 
  Visited farm, zoo, or stables  12 (57)  0.8 (0.3–2.4)  4.7 (1.3–17.4) 
Medical-related exposures 
  Admission to hospital in 12 mo before  
 diagnosis 
13 (62)  6.8 (1.9–24.4)  1.5 (0.4–5.2) 
  Someone in household with chronic condition  12 (57)  3.8 (1.2–12.5)  2.0 (0.8–9.3) 
  Antimicrobial drug use in 12 mo before  
 diagnosis 
9 (43)  3.4 (1.0–11.5)  2.6 (0.8–9.2) 
  Contact with person with skin sore or other  
 skin  infection 
5 (26)  8.6 (1–74.9)  0.6 (0.2–1.9) 
*MRSA, methicillin-resistant Staphylococcus aureus; CC, clonal complex. 
†p<0.01, by unmatched analysis. RESEARCH
owning or having contact with dog(s) or horse(s), prefer-
ence for eating pork, and being born outside Denmark.
Multivariable Analysis
Logistic regression models were applied separately 
to the case–control and case–case studies. In both studies, 
the ﬁ  rst model only included farm and animal-related ex-
posures: lived or worked on a farm with animals, worked 
with animals or meat, exposed to pigs, exposed to cattle, ex-
posed to other farm animals, provided antimicrobial drugs 
to animals, owned cat(s), and had contact with any farm 
workers. Other farm and animal exposures were excluded 
because of colinearity. In both case–control and case–case 
studies, living or working on a farm with animals remained 
the independent association in this ﬁ  rst model. A second 
model combined living or working on a farm with animals 
with medical-related exposures: contact with a person hav-
ing a skin sore or other skin infection, history of hospital 
admission in the 12 months before diagnosis, antimicrobial 
drug use in the 12 months before diagnosis, and someone 
in the household with a chronic condition.
Living or working on a farm with animals was an in-
dependent risk factor for CC398 in the case–control study 
(MOR 35.4, 95% conﬁ  dence interval [CI] 2.7–469.8) and 
the case–case study (MOR 14.5, 95% CI 2.7–76.7). A his-
tory of hospital admission in the 12 months before diag-
nosis was associated with an increased risk in the case–
control study (MOR 11.4, 95% CI 1.4–94.8) but not in the 
case–case study.
Farm Investigations
Nine pig farms and 2 cattle herds, with which 10 case-
patients had contact, were identiﬁ  ed. One case-patient had 
contact with 2 pig farms, and 2 case-patients had contact 
with the same pig farm. No controls or non-CC398 case-
patients had direct contact with a pig or cattle farm. The 
owners of 5 pig farms and of the 2 cattle herds agreed to 
participate in the study. The length of time between date of 
patient diagnosis and farm sampling was 2–24 months.
Microbiologic Analysis
All but 1 of 31 human isolates were nontypeable by 
PFGE after digestion with SmaI. Twenty-nine isolates had 
spa type t034, including the isolate typeable by PFGE, and 
the other 2 were related variants of t034 (t108 and t1793). 
Because of the strong correlation between spa typing and 
MLST, all isolates could be assigned to CC398. One isolate 
(PFGE nontypeable, spa type t034) was typed by MLST 
and conﬁ  rmed to be ST398. SCCmec typing showed that 
24 isolates harbored SCCmec type V. SCCmec type IV was 
also found in 2 isolates (PFGE nontypeable, spa type t034). 
Three isolates were ccrAB2 positive, which indicated ei-
ther a type II or type IV variant, but the mec class could 
not be determined. Two isolates were nontypeable. Isolates 
from the 21 case-patients were spa types t034 (SSCmec IV, 
n = 2, SSCmec V, n = 16, and a type II or type IV variant, 
n = 1, typeable by PFGE), t108 (SSCmec V, n = 1), and 
t1793 (SSCmec V, n = 1). These isolates showed consid-
erable variation in antimicrobial drug resistance patterns; 
most isolates were resistant to tetracycline and erythromy-
cin. All isolates from case-patients who reported exposure 
to pigs were tetracycline resistant and PVL negative. Two 
isolates were PVL positive; these were from case-patients 
who reported a connection to China. All isolates tested for 
exotoxin showed negative results for all toxins examined.
Twenty-three (46%) of 50 pigs on 4 of 5 sampled farms 
carried CC398 spa type t034. All isolates were resistant to 
tetracycline and trimethoprim. Pig isolates were indistin-
guishable or only differed by 1 additional antimicrobial 
drug class when compared with isolates from case-patients 
who had contact with them (Table 2). MRSA was not de-
tected in the 2 cattle herds.
Discussion
This study provides compelling epidemiologic and 
microbiologic evidence that persons living or working on 
farms in Denmark, particularly pig farms, are at increased 
risk of being colonized or infected with MRSA CC398. We 
provide evidence for pigs being a substantial reservoir of 
human MRSA CC398 in Denmark, as appears to be the 
case in other European countries such as the Netherlands 
and France (3,4,7,12), and in Canada (6).
In the case–case analysis, only animal and farm-related 
exposures were associated with being a case-patient, which 
indicates that these exposures are the major factors associ-
ated with CC398 acquisition. Furthermore, comparison of 
results from the case–control study (where farm/animal and 
medical-related variables remained associated) indicates that 
medical-related exposures are risk determinants for commu-
nity-detected MRSA in general but not speciﬁ  cally for sub-
type CC398. This ﬁ  nding can be deduced because the design 
of the case–case analysis controls for exposures common to 
both groups, which means that these exposures will not be 
identiﬁ  ed as a risk or might be underestimated (20).
Because of evidence of prolonged MRSA carriage 
(21), questions related to exposures referred to a period of 
1 year before patient diagnosis. This lengthy recall period 
is a limitation of this study. However, all questions related 
to memorable activities and lifestyle choices; any bias in-
troduced is therefore thought to be minimal.
Our ﬁ  nding that living or working on a farm with 
animals is associated with CC398 acquisition reinforces 
results of studies in France, the Netherlands, and Canada 
that indicated that CC398 is transmissible from animals 
to humans (3,4,6,7). Also in the Netherlands, a CC398 
prevalence of 3.9% in 179 veterinarians has been de-
1386  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 9, September 2008Pigs as Source of MRSA CC398 Infections, Denmark
scribed; all positive persons had recent or regular contact 
with pigs and cows (22). Screening participants from 38 
countries at a veterinary conference in Denmark in 2006 
found a CC398 prevalence of 9.6% (26/272); the highest 
prevalence was in German and Dutch delegates (23). In 
comparison, the prevalence of CC398 among delegates 
attending several national animal conferences in Denmark 
was 0.7% (4/576) (24).
Pig isolates from contact herds were indistinguishable, 
or only differed by 1 additional antimicrobial drug class, 
from the isolates from human case-patients who worked 
or lived on farms where these pigs were located. These 
samples were obtained months, in some cases years, after 
the human case-patient’s infection was diagnosed, ﬁ  ndings 
that lend weight to the hypotheses that CC398 carriage in 
animals is unlikely to be transient and that animals are a 
reservoir of CC398. Although we isolated CC398 from 23 
pigs on 4 of 5 pig farms, but not from cattle farms, this type 
may not be exclusive to pigs. CC398 has been shown to 
have a prevalence of 39% in pigs in the Netherlands (25). 
However, it has also been found in horses and dogs in Ger-
many and Austria (5) and in cattle and poultry in the Neth-
erlands (26,27). These ﬁ  ndings are particularly interesting 
because S. aureus is usually host speciﬁ  c (28).
Our study has highlighted other important human 
epidemiologic aspects of CC398. The clinical picture for 
CC398, with ≈50% of case-patients having had an infection 
and all reporting skin and soft tissue infections, is similar to 
that seen in community-acquired MRSA isolates in general 
(29,30). There was a serious invasive infection with MRSA 
reported in a man in Denmark after surgery on his knee; 
arthritis and multiorgan failure also developed (31). Seri-
ous complications from CC398 have also been described 
in other reports including ventilator-associated pneumonia 
(5) and endocarditis (32). Because no statistical association 
was found with travel abroad, this ﬁ  nding indicates that 
CC398 is endemic among pigs in Denmark. Nevertheless, 
there was an overrepresentation of case-patients or their 
family members who have had contact with another coun-
try, 2 with adopted children from China and 3 case-patients 
with relatives from the Netherlands. Likewise, in the Neth-
erlands, a child adopted from China was found to be an 
MRSA CC398 carrier in 2004 (12). Three family clusters 
were identiﬁ  ed in the present study, which indicates that 
CC398 can be transmitted from person to person. This ﬁ  nd-
ing is not surprising because of the adaptability of MRSA. 
Its potential for transmission between humans has also been 
observed in the Netherlands (4,7). MRSA has been isolated 
from dairy products, beef, chicken and pork (33–37) and 
although foodborne transmission is plausible (34), the risk 
is thought to be low. Preference for eating pork was not as-
sociated with being a CC398 case-patient in our study. 
A high degree of variability in the types of CC398 (re-
sistance patterns, spa types, and SCCmec types) suggests 
that this type is either rapidly evolving or emerging from a 
hitherto unrecognized reservoir. In the latter case, CC398 
must have been introduced into Denmark on more than 1 
occasion or by various routes to explain the high degree 
of variance. When one considers the rapid adaptability of 
MRSA, it may only be a matter of time before we see an in-
creased prevalence of CC398 in humans, including those in 
hospitals as has been recently reported in the Netherlands 
(12). A high prevalence of tetracycline resistance in CC398 
patients in contact with pigs has also been observed in the 
Netherlands; this ﬁ  nding suggests that use of tetracyclines 
and possibly other antimicrobial drugs in food animals is 
selecting these multidrug-resistant bacteria (25). Two case-
patients who were positive for PVL had direct connections 
to China. To our knowledge, there are no published reports 
of CC398 patients in China but isolates from pigs have re-
cently been reported from Singapore, with Indonesian ori-
gin (38).
In conclusion, transmission of CC398 from a zoonotic 
reservoir to humans could undermine existing MRSA con-
trol programs. We therefore recommend increased aware-
ness among healthcare professionals that animals are a 
possible source of MRSA infection and that the potential 
for person-to-person spread exists. To limit further spread, 
pig farmers may warrant screening and isolation on admis-
sion to hospitals as has been implemented in the Nether-
lands (39). However, further studies are required to better 
understand the human and veterinary epidemiology of this 
emerging zoonosis. Areas of study should include size of 
the reservoir in pigs, whether other animals constitute a res-
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isolates Resistance pattern  spa type 
1 2005 Mar  tet, ery, cli, str, tmp  t034 A 9 tet, ery, cli, str, spe, tmp  t034
2 2005 Oct  tet, tmp  t034 B 5 tet, tmp  t034
4 tet, str, tmp  t034
1 tet, str, tmp  t034
3 2006 Oct  tet, ery, cli, str, spe, tmp  t034 C 1 tet, ery, cli,str, spe, tmp  t034
2 tet, str, spe, tmp  t034
4 2006 Nov  tet, kan, str, spe, tmp  t034 D 1 tet, ery, cli, kan, str, spe, tmp  t034
*spa, staphylococcal protein A; tet, tetracycline; ery, erythromycin; cli, clindamycin; str, streptomycin; tmp, trimethoprim; spe, spectinomycin; kan, 
kananmycin.  RESEARCH
ervoir of CC398, and how frequently CC398 is transmit-
ted from animals to humans and from humans to humans. 
The European Union baseline survey on the prevalence of 
MRSA in breeding pigs, initiated in January 2008, is an 
important step in addressing the ﬁ  rst of these points (40). 
This study was supported by the Statens Serum Institut.
Ms Lewis is a fellow with the European Programme for In-
tervention Epidemiology Training at the Statens Serum Institut in 
Copenhagen. Her primary research interest is intervention epide-
miology, particularly in relation to zoonoses.
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